Catalent Biologics’ Expands Manufacturing Complex in Madison, Wisconsin
Catalent Biologics’ is expanding its cell line development and biomanufacturing site in Madison, Wisconsin. The company is investing $75 million and is expected to create at least 145 new jobs by the end of 2021.

Mammalian cell culture capacity will be increased at the site with the buildout of two new biomanufacturing suites, providing additional clinical and commercial production at the 2,000- or 4,000-liter batch scale. Overall, the project will add approximately 60,000 square feet to the existing facility. Expected to be completed by mid-2021, the expansion will more than double Catalent’s commercial biomanufacturing capacity at the site...   ...more

Ken Notes: Madison could become the Silicon Valley of biotech. And the industry could be almost as large. Most new medicines and food will come from the genetic modification of something...



- - Volume: 7 - WEEK: 39 Date: 9/26/2019 5:22:05 AM -